CVM

Cel Sci (CVM)

Cel Sci Corporation New

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:AMEX:CVM

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/10	22:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:CVM	Cel Sci Corporation New
2024/05/10	02:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:CVM	Cel Sci Corporation New
2024/05/09	22:19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:CVM	Cel Sci Corporation New
2024/05/08	22:00	Business Wire	CEL-SCI Receives FDA Go-Ahead for Its Confirmatory Study of Multikine in the Treatment of Head & Neck Cancer	AMEX:CVM	Cel Sci Corporation New
2024/04/23	22:00	Business Wire	CEL-SCI Appoints Mario Gobbo to Its Board of Directors	AMEX:CVM	Cel Sci Corporation New
2024/03/19	22:00	Business Wire	CEL-SCI’s LEAPS Vaccine Offers Promising New Paradigm to Treat Rheumatoid Arthritis: Published in Frontiers in Immunology	AMEX:CVM	Cel Sci Corporation New
2024/03/08	01:33	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	AMEX:CVM	Cel Sci Corporation New
2024/03/08	01:33	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	AMEX:CVM	Cel Sci Corporation New
2024/03/08	01:31	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	AMEX:CVM	Cel Sci Corporation New
2024/03/06	22:45	Business Wire	CEL-SCI Corporation Issues Letter to Shareholders	AMEX:CVM	Cel Sci Corporation New
2024/02/15	22:00	Business Wire	CEL-SCI Corporation Reports First Quarter Fiscal 2024 Financial Results	AMEX:CVM	Cel Sci Corporation New
2024/02/15	06:31	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	AMEX:CVM	Cel Sci Corporation New
2024/02/14	02:00	Business Wire	CEL-SCI Announces Closing of $7.75 Million Public Offering of Common Stock	AMEX:CVM	Cel Sci Corporation New
2024/02/09	22:44	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	AMEX:CVM	Cel Sci Corporation New
2024/02/09	22:30	Business Wire	CEL-SCI Announces Pricing of $7.75 Million Public Offering of Common Stock	AMEX:CVM	Cel Sci Corporation New
2024/02/06	23:00	Business Wire	CEL-SCI Completes Commissioning of Its Multikine Manufacturing Facility for Commercial Scale Production of Head & Neck Cancer Drug	AMEX:CVM	Cel Sci Corporation New
2024/01/31	23:00	Business Wire	European Medicines Agency Grants CEL-SCI a Waiver of Strict Pediatric Requirements, Clearing the Path Towards Marketing Authorization for Multikine®	AMEX:CVM	Cel Sci Corporation New
2024/01/02	23:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:CVM	Cel Sci Corporation New
2024/01/02	23:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:CVM	Cel Sci Corporation New
2024/01/02	23:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:CVM	Cel Sci Corporation New
2023/12/23	06:01	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	AMEX:CVM	Cel Sci Corporation New
2023/12/22	22:00	Business Wire	CEL-SCI Reports Fiscal 2023 Financial Results and Clinical & Corporate Developments	AMEX:CVM	Cel Sci Corporation New
2023/12/22	06:15	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	AMEX:CVM	Cel Sci Corporation New
2023/12/04	22:30	Business Wire	UK’S National Institute for Health and Care Excellence (NICE) Selects CEL-SCI’s Multikine as Potential New Standard of Care for Head & Neck Cancer	AMEX:CVM	Cel Sci Corporation New
2023/11/21	07:25	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:CVM	Cel Sci Corporation New
2023/11/21	06:15	Business Wire	CEL-SCI Announces Closing of $5 Million Public Offering of Common Stock	AMEX:CVM	Cel Sci Corporation New
2023/11/16	22:39	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	AMEX:CVM	Cel Sci Corporation New
2023/11/16	22:30	Business Wire	CEL-SCI Announces Pricing of $5 Million Offering of Common Stock	AMEX:CVM	Cel Sci Corporation New
2023/10/31	06:01	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:CVM	Cel Sci Corporation New
2023/10/30	22:20	Business Wire	CEL-SCI Issues Letter to Shareholders	AMEX:CVM	Cel Sci Corporation New